Key Findings
The United States proteomics market is expected to record a CAGR of 13.05% during the forecast period, 2022-2028. The market players in the country are increasingly investing in proteomics-related products, instruments, services, and technology.

Market Insights
The United States is home to the majority of key market players, which strengthens its market position globally. Proteomics has major applications in diseases diagnosis capabilities and its role in drug discovery and development. This increases its demands in the country. Also, the Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) supplements the application and development of proteogenomic/proteomic science to enhance cancer outcomes, treatments, and diagnosis by bringing resources and data to the research community, inquiring the molecular underpinnings of the disease, and identifying strategies and targets for precision oncology.

Further, the OCCPR overlooks the CPTAC (Clinical Proteomic Tumor Analysis Consortium), which facilitates the collaboration of prominent centers nationwide in a coordinated and comprehensive effort in terms of the application of large-scale genome and proteome analysis. Additionally, cancer is a prominent death cause in the country. As a result, proteomics application in research becomes necessary for treatment and diagnosis purposes. Such developments boost growth opportunities.

Competitive Insights
Some of the key companies in the market are Bruker Corporation, Thermo Fisher Scientific Inc, Agilent Technologies Inc, PerkinElmer Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments